The oncologists who have made the choice to join Oncotarget know there is a lot of hope that the publication has. They hope they can connect doctors, they hope the doctors can help each other with new treatment options and they hope they can begin helping patients feel better while dealing with cancer treatment. Because of all the things the publication hopes for, they know they will be able to make a big difference for people who have cancer and who are using oncologists who just want to make a difference. All of this has allowed people the chance to make sure they are doing things right and offering new opportunities to those who are trying to treat cancer. Because of the way people can do different things, they know what they are going to experience and they know they will have a chance to heal no matter what is going on with their treatment options. Learn more about Oncotarget at Eurekalert.org.
For those who have gone through cancer treatment, there are many options they can use. Even just browsing Research Gate allows people to see there are numerous treatment options they can try out. All of these go back to getting rid of cancer and eliminating the side effects that come along with treating it. There have been many advances in the past and all of these go back to how people can try to treat cancer and make cancer treatment better for everyone. It helps them make things easier and gives them hope for the future. Follow Oncotarget on Linkedin.
As long as there are new opportunities people can take advantage of, they are doing their best to provide other opportunities to those who are in need. Thanks to Oncotarget, there have been so many advances in cancer treatment. All of it comes back to how they can make people feel and how they can show others what they are getting out of the situations they are in. Bringing attention to these issues has allowed Oncotarget the chance to make sure people are getting what they need and are going to be able to help each other with the issues they are facing.
For decades, Eric Lefkofsky’s legacy rooted from his entrepreneurial ventures. One company he so ventured into in that time is Groupon, a $2.2 billion company that specialized in connecting clients with merchants. His legacy took a toll when his wife was diagnosed with breast cancer. Just like any other affected family, Eric was heartbroken by his wife’s health condition. He, however, focused on the good that would come out of it instead of crushing in depression. That is why he founded Tempus, a facility that has capitalized on developing modern data and resources for cancer treatment.
Since its establishment, Tempus has focused on developing a system for cancer treatment. The system is a platform for technology that links anatomic and molecular statistics with clinical statistics from medical facilities across the country. According to Eric, the data compiled in a central place gives a clear platform of understanding to physicians. The result is a precise and personalized treatment for patients. With Tempus in place, a combination of thermotherapy treatments and radiation would undergo adjustment for a patient’s need based on historical results. This occurs when patients have similar medical backgrounds in the country. The mechanism for this treatment method is based on their genetic combination in addition to the drugs they have taken.
According to Mr. White the president of Tempus, their efforts to fight cancer rooted from a shared vision to find cancer treatment. Kevin is also the founding director of Tempus. He closely works with Lefkofsky to develop innovative technology towards cancer treatment and therapies. Kevin’s role at Tempus is developing strategies for a successful product. Eric on the other side brings massive experience in building successful businesses focused on aggregating large data. He then transforms the statistics into useful figures and insights that can be employed in every state.
Eric’s entrepreneurial career began as a carpet selling business in the University of Michigan. After campus, he joined his business partner Bradley Keywell in borrowing money to invest in Brandon Apparel. In 1999, the duo invested in an internet company which focused on brand promotion. Starbelly was worth $240 million. Eric at Twitter .
www.forbes.com/profile/eric-lefkofsky for more .